Nutrafol AI Market Strategy Report - Hair Loss Treatments

Answer Capsule

Nutrafol leads the Hair Loss Treatments category with the highest AI Authority Value at $3.9M and the strongest valid recommendation coverage at 24.9%. The brand appears in 47.4% of all AI observations across six platforms, the highest presence rate in the category. Nutrafol's clearest win is broad and consistent recommendation power across all major platforms, particularly in the high-intent pricing cluster. The clearest weakness is a net sentiment score of 0.57, which trails Rogaine (0.69) and Happy Head (0.80), suggesting room to improve how AI systems frame the brand. The clearest opportunity is converting its already strong visibility assist value of $1.28M into direct recommendation value by strengthening the clinical citation architecture that supports rank-one recommendations.

Who This Report Is For

This report is for Nutrafol's marketing, brand strategy, and growth leadership teams evaluating AI recommendation-stage visibility and competitive positioning in the hair loss treatment category.

Report Card

• Report type: AI Company Market Strategy Report
• Target company: Nutrafol
• Category / market studied: Hair Loss Treatments
• Reporting month: June 2026
• AI platforms tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity
• Public high-intent clusters: 3 (Best Telehealth and Online Prescription Services, Telehealth Platform Comparisons, Telehealth and Online Prescription Pricing)
• AI observations analyzed: 1,102
• Competitors tracked: 9 (Hims, Bosley, Folexin, HairClub, Happy Head, Keeps, Propecia by Merck, Ro (Roman), Rogaine)

Executive Summary

Nutrafol holds the strongest AI recommendation position in the Hair Loss Treatments category for June 2026. The LLM Authority Index benchmark shows Nutrafol with a monthly AI Authority Value of $3.9M, capturing 7.3% of the total $53.2M monthly AI opportunity. This leadership is built on broad and consistent recommendation coverage across all six tracked platforms, with a valid recommendation coverage of 24.9% and a top-10 rate of 22.7%.

The brand's strength is most pronounced in the Telehealth and Online Prescription Pricing cluster, where it achieves a 26.9% top-10 rate and captures $1.6M in modeled value. This is the highest-intent buying moment in the category, where consumers are evaluating cost and ready to act. Nutrafol also leads on Copilot (30.9% recommendation coverage), Gemini (27.6%), Google AI Mode (30.4%), and Google AI Overviews (28.0%).

Nutrafol appears in 522 of 1,102 observations, with 304 positive mentions, 212 neutral mentions, and 6 negative mentions. The net sentiment score of 0.57 is solid but trails Rogaine (0.69), Happy Head (0.80), and Hims (0.70). The neutral mention count of 212 is the most important signal in this framing gap: many AI responses list Nutrafol without endorsing it, which reduces the commercial weight of each appearance.

The most important structural pattern in the data is that Nutrafol's recommendation power is broad rather than concentrated at rank one. Rogaine achieves a 14.2% rank-one rate compared to Nutrafol's 8.7%, and Rogaine's average recommended rank of 1.58 is sharper than Nutrafol's 2.24. Nutrafol wins on breadth and category presence; Rogaine wins on first-choice frequency. That gap represents the clearest strategic priority for the brand heading into the second half of 2026.

What Nutrafol Is Winning

Strongest overall recommendation coverage. Nutrafol achieves a valid recommendation coverage of 24.9%, the highest in the category. In nearly one in four observations where Nutrafol appears, it receives a positive, shortlist-quality recommendation. No other tracked brand matches this breadth.

Dominance in the pricing cluster. The Telehealth and Online Prescription Pricing cluster carries a $17.0M modeled opportunity and the highest buyer-stage multiplier in the public report. Nutrafol leads here with a 26.9% top-10 rate and $1.6M in captured modeled value. This is the cluster where purchase decisions are made, and Nutrafol is the most recommended option in it.

Cross-platform consistency. Nutrafol leads on four of six platforms: Copilot (30.9%), Gemini (27.6%), Google AI Mode (30.4%), and Google AI Overviews (28.0%). This platform breadth means Nutrafol's recommendation power is not dependent on a single AI system, which is a more durable competitive position than platform-concentrated leadership.

Highest raw mention presence. Nutrafol appears in 47.4% of all observations, the highest presence rate in the category. This indicates strong brand recognition and retrievability across the public evidence layer.

Low negative framing. Only 6 of 522 Nutrafol observations carry negative sentiment. The brand is overwhelmingly presented in positive or neutral terms, which is a strong foundation for continued recommendation conversion work.

Where Nutrafol Has the Clearest AI Visibility Gaps

Rank-one recommendation rate trails Rogaine significantly. Nutrafol's rank-one rate of 8.7% is well behind Rogaine's 14.2%. When AI systems surface a single first choice, they select Rogaine more often than Nutrafol. This gap is sharpest on ChatGPT, where Rogaine achieves a 25.1% rank-one rate compared to Nutrafol's 2.9%. The average recommended rank difference (Rogaine at 1.58 versus Nutrafol at 2.24) reinforces that Nutrafol tends to land in second or third position rather than first across multi-recommendation responses.

Weak performance on ChatGPT. On ChatGPT, Nutrafol's valid recommendation coverage drops to 5.7%, far below its category-leading performance on other platforms. Rogaine captures 19.8% of the ChatGPT recommendation opportunity by comparison. The sentiment data shows that 42 of Nutrafol's 52 ChatGPT mentions are neutral, meaning the platform is listing rather than recommending the brand. ChatGPT's scale and consumer reach make this the most commercially consequential platform gap in the dataset.

High neutral mention share reduces framing quality. Nutrafol's 212 neutral mentions represent 40.6% of its total observations. Neutral mentions contribute zero to the sentiment score and zero to valid recommendation credit. This volume suggests that AI systems frequently retrieve Nutrafol as a known brand without using it as an active recommendation. Closing this gap requires improving the framing quality of the content and citation sources that AI systems encounter when Nutrafol's name appears.

Visibility assist value is a meaningful share of total AI Authority Value. Nutrafol's visibility assist value of $1.28M represents 32.8% of its total AI Authority Value of $3.9M. By comparison, Rogaine's visibility assist share is 18.7%, meaning a higher proportion of Rogaine's AI value derives from direct recommendations rather than assisted mentions. Nutrafol's overall leadership position is real, but a portion of it reflects presence without recommendation conversion.

Biggest Opportunity

The data points to one clear move: convert Nutrafol's broad visibility assist value into rank-one recommendation power by strengthening the clinical citation architecture that AI systems use to justify first-choice recommendations.

Nutrafol already has the highest presence rate and the broadest valid recommendation coverage in the category. The gap is not in being known; it is in being chosen first. The benchmark evidence suggests that Rogaine holds stronger rank-one positions because it benefits from extensive clinical study references, dermatologist-authored review content, and structured comparison pages that AI systems can retrieve and cite with high confidence. These source types appear to support the kind of definitive recommendation framing that produces rank-one outputs.

Nutrafol's priority should be ensuring that its clinical evidence, ingredient-level research, and dermatologist endorsements are structured and consistently accessible through the source formats that ChatGPT, Perplexity, and Copilot prioritize. On those three platforms, Nutrafol's recommendation coverage and rank-one rate lag most significantly. A targeted citation layer investment focused on those platforms and on comparison-format content could close the rank-one gap without requiring a broad increase in general brand spending.

Prompt Evidence

Copilot / Telehealth and Online Prescription Pricing Prompt: "What is the best hair loss treatment for women?" Result: Nutrafol was recommended as the top option, appearing in the top-three position with positive framing tied to its supplement-based approach and clinical study references.

ChatGPT / Telehealth Platform Comparisons Prompt: "Compare Nutrafol and Rogaine for hair loss." Result: Rogaine was positioned as the first choice with rank-one placement. Nutrafol appeared in the response but was listed second with neutral comparison framing rather than a direct recommendation.

Google AI Overviews / Best Telehealth and Online Prescription Services Prompt: "Best online hair loss treatment services 2026." Result: Nutrafol appeared in the top-three recommendations with positive framing, alongside Keeps and Rogaine, consistent with its strong performance on this platform.

Perplexity / Telehealth and Online Prescription Pricing Prompt: "How much does Nutrafol cost per month?" Result: Nutrafol was mentioned with pricing information but was not ranked or recommended relative to competitors. The response was factual and neutral, consistent with Perplexity's 0.45 sentiment score for Nutrafol in this dataset.

What CiteWorks Studio Would Do Next

Phase 1: AI Market Discovery Audit Map Nutrafol's full recommendation footprint across all 10 tracked clusters, including the 7 clusters not covered in the public report, to identify prompt-level wins and losses by platform and buying stage.

Phase 2: Recommendation Readiness Plan Diagnose why Nutrafol's rank-one rate trails Rogaine on ChatGPT and Perplexity, and identify the specific citation and framing gaps that prevent first-choice recommendations on those platforms.

Phase 3: Owned Answer Layer Buildout Develop structured content for Nutrafol's clinical studies, ingredient research, dermatologist reviews, and direct comparison pages in formats that AI systems can retrieve and cite as evidence for rank-one recommendations.

Phase 4: Citation / Authority Layer Development Strengthen the public evidence layer by ensuring Nutrafol's clinical data, efficacy studies, and category comparison content are accessible through the source types that ChatGPT, Perplexity, and Copilot prioritize when forming first-choice recommendations.

Phase 5: Monthly AI Visibility and Recommendation Tracking Monitor Nutrafol's recommendation coverage, rank-one rate, sentiment score, and visibility assist share across all six platforms monthly to measure whether citation architecture improvements are producing recommendation conversion.

Why This Matters

Nutrafol holds the strongest AI recommendation position in the hair loss treatment category, but the data separates presence from first-choice power. Rogaine is being chosen first more often, particularly on ChatGPT and Perplexity, where AI-generated shortlists have the most direct influence on consumer purchase decisions. For Nutrafol, the next move is not about increasing brand presence; it is about converting broad recommendation coverage into rank-one frequency in the clusters where buyers make final choices.

The brands that secure rank-one positions in high-intent clusters will capture a disproportionate share of the commercial value as AI-led discovery becomes a standard part of the consumer buying journey. Nutrafol is closer to that position than any other brand in this category. The remaining gap is a citation architecture and framing quality problem, not a recognition problem, and that is a more solvable problem than rebuilding brand presence from a weaker starting point.

Core Metrics

• Mentions: 522
• Valid recommendations: 274
• Top 3 recommendation count: 210
• Rank 1 recommendation count: 96
• Average recommended rank: 2.24
• Positive mentions: 304
• Neutral mentions: 212
• Negative mentions: 6
• Raw mention presence rate: 47.4%
• Valid recommendation coverage: 24.9%
• Top 3 recommendation rate: 19.1%
• Rank 1 recommendation rate: 8.7%
• Strongest cluster by recommendation behavior: Telehealth and Online Prescription Pricing (26.9% top-10 rate)
• Strongest platform by recommendation behavior: Copilot (30.9% recommendation coverage)

Sentiment Score

Sentiment Score = (positive mentions x 1 + neutral mentions x 0 + negative mentions x -1) / total mentions

Nutrafol Sentiment Score = (304 x 1 + 212 x 0 + 6 x -1) / 522 = 298 / 522 = 0.57

This score means that 57% of Nutrafol's mentions carry net positive framing after accounting for neutral and negative observations. While the score is solid, the high neutral count of 212 is the most important signal in this number. Many AI responses retrieve and list Nutrafol without endorsing it, which means a large portion of the brand's AI presence is generating awareness rather than recommendation credit.

Unclassified mention counts are misleading because they treat a neutral listing and a positive recommendation as equal signals. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equivalent, and counting all four as wins produces measurement that cannot support a prioritized strategy. Classified sentiment, separated into positive, neutral, and negative, is required before AI visibility data can be interpreted with commercial precision.

Sentiment by Platform

Methodology

1. This report is a benchmark-based AI Company Market Strategy Report for Nutrafol in the Hair Loss Treatments category, produced by CiteWorks Studio using LLM Authority Index benchmark data.
2. The reporting window is June 2026. This is a point-in-time benchmark. AI model outputs can change as models update and source material shifts.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, and Perplexity.
4. A total of 1,102 observations were analyzed across three public high-intent prompt clusters. The full LLM Authority Index report includes 10 clusters; this public version covers 3.
5. The competitor universe includes 10 brands: Nutrafol, Rogaine, Keeps, Hims, Happy Head, Bosley, HairClub, Ro (Roman), Folexin, and Propecia (Merck).
6. The three public high-intent clusters reported are: Best Telehealth and Online Prescription Services (consideration stage), Telehealth Platform Comparisons (evaluation stage), and Telehealth and Online Prescription Pricing (decision stage). Seven additional clusters exist in the full report and are not reflected in these figures.
7. Stage 0 refers to the raw observation collection stage in which AI responses are captured and cataloged before metric calculation, sentiment classification, or ranking assignment.
8. A mention is defined as any instance of a company appearing in an AI-generated response, regardless of sentiment, rank, or recommendation status.
9. A valid recommendation is defined as a positive, shortlist-quality mention that earns recommendation credit. This is distinct from a raw mention, a neutral reference, or a cautionary appearance.
10. Modeled AI Authority Value and visibility assist value are directional estimates based on the LLM Authority Index benchmark methodology. They are not revenue figures, pipeline values, or ROI projections.
11. Ahrefs or organic search data were not used in this report. All AI recommendation metrics derive from the LLM Authority Index dataset. If traditional search and source layer analysis were incorporated in a full audit, those signals would serve as supporting evidence for the public evidence layer, not as AI recommendation proxies.
12. Limitations: This report reflects the public three-cluster version of the June 2026 LLM Authority Index benchmark. Results cover a defined prompt set and observation window. They represent a structured sample of AI output, not a complete census of all possible AI responses in the category.

See How AI Is Recommending Your Brand

The public benchmark establishes where Nutrafol stands in the category and where competitors are capturing rank-one positions. A company-specific analysis would map which prompts Nutrafol wins and loses at the platform level, which source layers are shaping neutral versus positive framing, and which citation gaps are preventing first-choice recommendations on ChatGPT and Perplexity. Contact CiteWorks Studio to request an AI Visibility Audit that identifies the specific recommendation-stage gaps your competitors are already working to close.